Global Transdermal Drug Delivery Partnering 2010-2016: Deal trends, players, financials and forecasts is intended to provide the reader with an in-depth understanding and access to Transdermal Drug Delivery trends and structure of deals entered into by leading companies worldwide.
The report takes the reader through a comprehensive review Transdermal Drug Delivery deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Transdermal Drug Delivery partnering deals.
The report presents financial deal term values for Transdermal Drug Delivery deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.
One of the key highlights of the report is that over 150 online deal records of actual Transdermal Drug Delivery deals, as disclosed by the deal parties, are included towards the end of the report in a directory format- by company A-Z, stage of development, deal type, therapy focus, and technology type- that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.
In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered- contract documents provide this insight where press releases and databases do not.
Transdermal Drug Delivery Partnering Terms and Agreements includes:
- Trends in Transdermal Drug Delivery dealmaking in the biopharma industry since 2010
- Analysis of Transdermal Drug Delivery deal structure
- Access to headline, upfront, milestone and royalty data
- Case studies of real-life Transdermal Drug Delivery deals
- Access to Transdermal Drug Delivery contract documents
- Leading Transdermal Drug Delivery deals by value since 2010
- Most active Transdermal Drug Delivery dealmakers since 2010
In Global Transdermal Drug Delivery Partnering 2010-2016: Deal trends, players, financials and forecasts, the available deals are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Specific therapy target
- Technology type
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in Transdermal Drug Delivery dealmaking
Chapter 3 - Leading Transdermal Drug Delivery deals
Chapter 4 - Most active Transdermal Drug Delivery dealmakers
Chapter 5 - Transdermal Drug Delivery contracts dealmaking directory
Chapter 6 - Transdermal Drug Delivery dealmaking by technology type
Chapter 7 - Partnering resource center
For more information about this report visit http://www.researchandmarkets.com/research/86x853/global
Related Topics: Transdermal and Transmucosal Drug Delivery
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-transdermal-drug-delivery-partnering-deal-trends-players-financials-and-forecasts-analysis-2010-2016---research-and-markets-300323800.html
SOURCE Research and Markets